Cite
Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021).
MLA
Kariyawasam, Ruwandi M., et al. “Antimicrobial Resistance (AMR) in COVID-19 Patients: A Systematic Review and Meta-Analysis (November 2019–June 2021).” Antimicrobial Resistance & Infection Control, vol. 11, no. 1, Mar. 2022, pp. 1–18. EBSCOhost, https://doi.org/10.1186/s13756-022-01085-z.
APA
Kariyawasam, R. M., Julien, D. A., Jelinski, D. C., Larose, S. L., Rennert-May, E., Conly, J. M., Dingle, T. C., Chen, J. Z., Tyrrell, G. J., Ronksley, P. E., & Barkema, H. W. (2022). Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021). Antimicrobial Resistance & Infection Control, 11(1), 1–18. https://doi.org/10.1186/s13756-022-01085-z
Chicago
Kariyawasam, Ruwandi M., Danielle A. Julien, Dana C. Jelinski, Samantha L. Larose, Elissa Rennert-May, John M. Conly, Tanis C. Dingle, et al. 2022. “Antimicrobial Resistance (AMR) in COVID-19 Patients: A Systematic Review and Meta-Analysis (November 2019–June 2021).” Antimicrobial Resistance & Infection Control 11 (1): 1–18. doi:10.1186/s13756-022-01085-z.